Orthopedic Clinical Research Studies

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Los Angeles County-USC Medical Center

mi

from

Los Angeles, CA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Pacific Neuroscience Research Institute

mi

from

Oxnard, CA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

University of California at San Francisco (UCSF)

mi

from

San Francisco, CA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Associated Neurologist of Southern Connecticut

mi

from

Fairfield, CT

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Yale University School of Medicine

mi

from

New Haven, CT

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Georgetown Univ Med Ctr

mi

from

Washington,

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Boca Raton Hospital

mi

from

Boca Raton, FL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

University of Miami Hospital

mi

from

Miami, FL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Parkinson's Disease Treatment Center of Southwest Florida

mi

from

Port Charlotte, FL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Department of Neurology, Movement St. Petersburg

mi

from

St Petersburg, FL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Univeristy of South Florida

mi

from

Tampa, FL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

1100 Johnson Ferry Road NE suite 420

mi

from

Atlanta, GA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Department of Neurology, Movement, Disorders Program

mi

from

Augusta, GA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Rush University Medical Center

mi

from

Chicago, IL

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

QUEST Research Institute

mi

from

Southfield, MI

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Kingston Neurological Associates

mi

from

Kingston, NY

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Island Neurological Associates

mi

from

Plainview, NY

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Neurological Disorders Clinic

mi

from

Durham, NC

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Wake Forest University Baptist Medical Center

mi

from

Winston-Salem, NC

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

The Cleveland Clinic

mi

from

Cleveland, OH

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Oregon Health and Science University

mi

from

Portland, OR

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Allegheny Endocrinology Associates

mi

from

Pittsburgh, PA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Vanderbilt University Medical Center

mi

from

Nashville, TN

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Baylor School of Medicine

mi

from

Houston, TX

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Evergreen Hospital Medical Center

mi

from

Kirkland, WA

Study Comparing Short Term Efficacy of DysportÂ® and Dysport RUÂ® to Placebo, and to Assess Efficacy and Safety of Dysport RUÂ® of Subjects With Cervical Dystonia

A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (DysportÂ® and Dysport RUÂ®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RUÂ® Following Repeated Treatments of Subjects With Cervical Dystonia

Status: Archived

Swedish Medical Center

mi

from

Seattle, WA

Helping Patients With Spinal Stenosis Make a Treatment Decision: A Randomized Study Assessing The Benefits of Health Coaching

Status: Archived

Darien Pediatric Associates

mi

from

Darien, CT

Growth Hormone Therapy in Osteogenesis Imperfecta

Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Evaluation and Intervention for the Effects of Osteogenesis Imperfecta

Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants

Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients With Debilitating Hematologic Diseases

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Study of Proteins Associated With Complex Regional Pain Syndrome

Complex Regional Pain Syndrome Proteomics Study

Status: Enrolling
Updated: 12/31/1969

National Institutes of Health Clinical Center, 9000 Rockville Pike

mi

from

Bethesda, MD

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial

Status: Enrolling
Updated: 12/31/1969

Huntsman Cancer Institute at University of Utah

mi

from

Salt Lake City, UT

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial

Status: Enrolling
Updated: 12/31/1969

LDS Hospital

mi

from

Salt Lake City, UT

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial

Status: Enrolling
Updated: 12/31/1969

VA Puget Sound Health Care System

mi

from

Seattle, WA

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial

Status: Enrolling
Updated: 12/31/1969

Fred Hutch/University of Washington Cancer Consortium

mi

from

Seattle, WA

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial

Status: Enrolling
Updated: 12/31/1969

University of Torino

mi

from

Torino,

Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men

Status: Enrolling
Updated: 12/31/1969

National Institute of Aging, Clinical Research Unit

mi

from

Baltimore, MD

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)

Status: Enrolling
Updated: 12/31/1969

Kennedy Krieger Institute

mi

from

Baltimore, MD

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)

Status: Enrolling
Updated: 12/31/1969

Oregon Health and Science University

mi

from

Portland, OR

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)

Status: Enrolling
Updated: 12/31/1969

Baylor College of Medicine, Department of Molecular and Human Gentics

mi

from

Houston, TX